Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes

Toxicology and Applied Pharmacology

Volumn 183, Issue 3, 2002, Pages 168-178

  Buesen, Roland ^a   Mock, Melissa ^a   Seidel, Albrecht ^b   Jacob, Jürgen ^b   Lampen, Alfonso ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Prof Dr Gernot Grimmer Foundation   (Germany)

Author keywords

Active transport; Benzo a pyrene; Caco 2 cells; CYP; Metabolism

Indexed keywords

9,10 DIHYDROXYBENZO[A]PYRENE; ABC TRANSPORTER; BENZO[A]PYRENE; BENZO[A]PYRENE 1 SULFATE; BENZO[A]PYRENE 3 GLUCURONIDE; BENZO[A]PYRENE 3 SULFATE; BENZO[A]PYRENE 3,6 DIONE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN; CELL STRAIN CACO 2; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; INTESTINE CELL; PROTEIN METABOLISM; PROTEIN TRANSPORT; SMALL INTESTINE;

EID: 0036395143     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2002.9484     Document Type: Article

References (51)

1. Allen, S. W., Mueller, L., Williams, S. N., Quattrochi, L. C., and Raucy, J. (2001). The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression. Drug Metab. Dispos. 29, 1074-1079.
2. Artursson, P., and Karlsson, J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, 880-885.
3. Artursson, P., Palm, K., and Luthman, K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Delivery Rev. 46, 27-43.
4. Autrup, H., Grafstrøm, R. C., Brugh, M., Lechner, J. F., Haugen, A., Trump, B. F., and Harris, C. C. (1982). Comparison of benzo[a]pyrene metabolism in bronchus, esophagus, colon, and duodenum from the same individual. Cancer Res. 42, 934-938.
5. Baranczyk-Kuzma, A., Garren, J. A., Hidalgo, I. J., and Borchardt, R. T. (1991). Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. Life Sci. 49, 1197-1206.
6. Barry, P. H., and Diamond, J. M. (1984). Effects of unstirred layers on membrane phenomena. Physiol. Rev. 64, 763-872.
7. Bartels, H., Korsiak, E., and Daniel, H. (1994). Transport activity of the MDR1-gene product in monolayers of Caco-2 cells. Z. Gastroenterol. 32, 15 -18.
8. Boulenc, X., Bourrie, M., Fabre, I., Roque, C., Joyeux, H., Berger, Y., and Fabre, G. (1992). Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2. J. Pharmacol. Exp. Ther. 263, 1471-1478.
9. Brooks, R. A., Gooderham, N. J., Edwards, J. R., Boobis, A. R., and Winton, D. J. (1999). The mutagenicity of benzo[a]pyrene in mouse small intestine. Carcinogenesis 20, 109-114.
10. Chang, T. K., Gonzalez, F. J., and Waxman, D. J. (1994). Evaluation of triacetyl-oleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Biochem. Biophys. 311, 437-442, doi: 10.1006/abbi.1994.1259.
11. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
12. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1653.
13. Dietrich, C. G., de Waart, D. R., Ottenhoff, R., Schoots, I. G., and Elferink, R. P. (2001). Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. Mol. Pharmacol. 59, 74-80.
14. Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude, R. P., Baas, F., Schinkel, A. H., and Borst, P. (1998). Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101, 1310-1319.
15. Fontana, R. J., Lown, K. S., Paine, M. F., Fortlage, L., Santella, R. M., Felton, J. S., Knize, M. G., Greenberg, A., and Watkins, P. B. (1999). Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117, 89-98.
16. Foth, H., Kahl, R., and Kahl, G. F. (1988). Pharmacokinetics of low doses of benzo[a]pyrene in the rat. Food Chem. Toxicol. 26, 45-51.
17. Glatt, H., Seidel, A., Ribeiro, O., Kirkby, C., Hirom, P., and Oesch, F. (1987). Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene. Carcinogenesis 8, 1621-1627.
18. Gottesman, M. M., and Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
19. Guengerich, F. P. (1992). Characterization of human cytochrome P450 enzymes. FASEB J. 6, 745-748.
20. Gutmann, H., Fricker, G., Torok, M., Michael, S., Beglinger, C., and Drewe, J. (1999). Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm. Res. 16, 402-407.
21. Hirohashi, T., Suzuki, H., Chu, X. Y., Tamai, I., Tsuji, A., and Sugiyama, Y. (2000). Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292, 265-270.
22. Hunter, J., Jepson, M. A., Tsuruo, T., Simmons, N. L., and Hirst, B. H. (1993). Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells: Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268, 14991-14997.
23. Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., and Grove, J. R. (1999). MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm. Sci. 88, 28-33.
24. Jacob, J., and Grimmer, G. (1996). Metabolism and excretion of polycyclic aromatic hydrocarbons in rat and in human. Cent. Eur. J. Public Health 4 (Suppl.), 33-39.
25. Kleinow, K. M., James, M. O., Tong, Z., and Venugopalan, C. S. (1998). Bioavailability and biotransformation of benzo[a]pyrene in an isolated perfused in situ catfish intestinal preparation. Environ. Health Perspect. 106, 155-166.
26. Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., Fang, C., and Watkins, P. B. (1992). Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J. Clin. Invest. 90, 1871-1878.
27. Lampen, A., Bader, A., Bestmann, T., Winkler, M., Witte, L., and Borlak, J. T. (1998). Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica 28, 429-441.
28. Lampen, A., Christians, U., Bader, A, von Engelhardt, W., and Sewing, K. F. (1996). Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber. Br. J. Pharmacol. 117, 1730-1734.
29. Lampen, A., Christians, U., Guengerich, F. P., Watkins, P. B., Kolars, J. C., Bader, A., Hackbarth, I., and Sewing, K. F. (1995). Metabolism of the immunosuppressant tacrolimus in the small intestine: Cytochrome P450, drug interactions, and interindividual variability. Drug Metab. Dispos. 23, 1315-1324.
30. Lampen, A., Meyer, S., Arnhold, T., and Nau, H. (2000). Metabolism of vitamin A and its active metabolite all-tran-retinoic acid in small intestinal enterocytes. J. Pharmacol. Exp. Ther. 295, 979-985.
31. Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., and Keppler, D. (1994). The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810.
32. Makhey, V. D., Guo, A., Norris, D. A., Hu, P., Yan, J., and Sinko, P. J. (1998). Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm. Res. 15, 1160-1167.
33. Münzel, P. A., Schmohl, S., Heel, H., Kalberer, K., Bock-Hennig, B. S., and Bock, K. W. (1999). Induction of human UDP-glucuronosyltransferases (UGT1A6, UGT1A9 and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab. Dispos. 27, 569-573.
34. Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., and Willingham, M. C. (1988). A retrovirus carrying a MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA 85, 4486-4490.
35. Peters, W. H., and Roelofs, H. M. (1989). Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem. J. 264, 613-616.
36. Pinto, M., Robine-Leon, S., Appay, M. D., Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, B., Simon-Assmann, P., Haffen, K., Fogh, J., and Zweibaum, A. (1983). Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2. Biol. Cell 473, 323-330.
37. Raftogianis, R. B., Wood, T. C., Otterness, D. M., Van Loon, J. A., and Weinshilboum, R. M. (1997). Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Commun. 239, 298-304, doi: 10.1006/bbrc.1997.7466.
38. Ribeiro, O., Kirkby, C. A., Hirom, P. C., and Millburn, P. (1986). Reactive intermediates from 3-hydroxybenzo[a]pyrene and its glucuronide. Carcinogenesis 7, 481-484.
39. Schuetz, E. G., and Schinkel, A. H. (1999). Drug disposition as determined by the interplay between drug-transporting and drug-metabolizing systems. J. Biochem. Mol. Toxicol. 13, 219-222.
40. Schuetz, E. G., Beck, W. T., and Schuetz, J. D. (1996). Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49, 311-318.
41. Schuetz, E. G., Yasuda, K., Arimori, K., and Schuetz, J. D. (1998). Human mdr1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo[a]pyrene. Arch. Biochem. Biophys. 350, 340-347, doi: 10.1006/abbi.1997.0537.
42. Shimada, T., Yamazaki, H., Foroozesh, M., Hopkins, N. E., Alworth, W. L., and Guengerich, F. P. (1998). Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2 and 1B1. Chem. Res. Toxicol. 11, 1048-1056.
43. Taipalensuu, J., Tornblom, H., Lindberg, G., Einarsson, C., Sjoqvist, F., Melhus, H., Garberg, P., Sjostrom, B., Lundgren, B., and Artursson, P. (2001). Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299, 164-170.
44. Tassaneeyakul, W., Birkett, D. J., Veronese, M. E., McManus, M. E., Tukey, R. H., Quattrochi, L. C., Gelboin, H. V., and Miners, J. O. (1993). Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther. 265, 401-407.
45. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84, 7735-7738.
46. Versandtvoort, C. H., Bagrij, T. Wright, K. A., and Twentyman, P. R. (1995). On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer 63, 855-862.
47. Wacher, V. J., Salphati, L., and Benet, L. Z. (2001). Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Delivery Rev. 46, 89-102.
48. Walgren, R. A., Karnaky, K. J., Jr., Lindenmayer, G. E., and Walle, T. (2000). Efflux of dietary flavonoid quercetin 4′-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Ther. 294, 830-836.
49. Walker, N. J., Portier, C. J., Lax, S. F., Crofts, F. G., Li, Y., Lucier, G. W., and Sutter, T. R. (1999). Characterization of the dose-response of CYP1B1, CYP1A1 and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 154, 279-286, doi: 10.1006/taap.1998.8595.
50. Walle, U. K., and Walle, T. (1999). Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: Role of efflux pumps. Carcinogenesis 11, 2153-2157.
51. Zhang, Q. Y., He, W., Dunbar, D., and Kaminsky, L. (1997). Induction of CYP1A1 by 3-naphthoflavone in IEC-18 rat intestinal epithelial cells and potentiation of induction by dibutyryl cAMP. Biochem. Biophys. Res. Commun. 233, 623-626, doi: 10.1006/bbrc.1997.6508.